Jingjing Feng
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications
Ultralow-Dose Interleukin 10-Expressing Chimeric Antigen Receptor T Cells in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Nonrandomized Clinical Trial.
Journal: JAMA oncology
Published: July 23, 2026
NOTCH3 Internal Tandem Duplication Defines a Novel Oncogenic Activation Mechanism of NOTCH Signaling.
Journal: Genes, chromosomes & cancer
Published: May 14, 2026
Explosive multi-site metastasis temporally associated with acute exacerbation of idiopathic pulmonary fibrosis in a patient with surgically resected lung squamous cell carcinoma: a case report.
Journal: Frontiers in medicine
Published: May 07, 2026
FUS/EWSR1::TFCP2-rearranged bone and soft tissue tumors: evidence of gene promiscuity.
Journal: Virchows Archiv : an international journal of pathology
Published: March 18, 2026
FFA4 inhibits bleomycin-induced pulmonary fibrosis in mice by suppressing IL-33.
Journal: Biochemical and biophysical research communications
Published: March 13, 2026
Combining co-expression analysis and machine learning to explore the diagnostic value of complement and coagulation cascade-related genes in asthma and the functional role of SERPINB2.
Journal: Briefings in functional genomics
Published: March 10, 2026
Genetic Mutation and Epigenetic Silencing Drive Antigen-Negative Relapse in CD7 CAR-T Treated T-cell Lymphoid Malignancies.
Journal: Blood cancer discovery
Published: January 05, 2026
CD19/BCMA-Targeted Chimeric Antigen Receptor-T Cell Therapy for Anti-HLA Antibody Sensitisation in Patients With Acute Leukaemia: A Pilot Clinical Study.
Journal: HLA
Published: November 23, 2025
Analysis of Respiratory Microbiota Characteristics in Patients with COPD and High-Risk Populations Using 16S rRNA Technology.
Journal: International journal of chronic obstructive pulmonary disease
Published: November 09, 2025
Safety and efficacy of CD19-targeted CAR-T-cell therapy for patients with relapsed or refractory TCF3-PBX1 fusion gene-positive B-ALL.
Journal: Hematology (Amsterdam, Netherlands)
Published: September 03, 2025
Last Updated: 09/26/2026